381 related articles for article (PubMed ID: 15491150)
1. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Roche TE
Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Hiromasa Y; Roche TE
Biochemistry; 2004 Oct; 43(42):13442-51. PubMed ID: 15491151
[TBL] [Abstract][Full Text] [Related]
3. Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase.
Hiromasa Y; Roche TE
J Biol Chem; 2003 Sep; 278(36):33681-93. PubMed ID: 12816949
[TBL] [Abstract][Full Text] [Related]
4. Marked differences between two isoforms of human pyruvate dehydrogenase kinase.
Baker JC; Yan X; Peng T; Kasten S; Roche TE
J Biol Chem; 2000 May; 275(21):15773-81. PubMed ID: 10748134
[TBL] [Abstract][Full Text] [Related]
5. Critical role of specific ions for ligand-induced changes regulating pyruvate dehydrogenase kinase isoform 2.
Hiromasa Y; Roche TE
Biochemistry; 2008 Feb; 47(8):2298-311. PubMed ID: 18220414
[TBL] [Abstract][Full Text] [Related]
6. Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates.
Liu S; Gong X; Yan X; Peng T; Baker JC; Li L; Robben PM; Ravindran S; Andersson LA; Cole AB; Roche TE
Arch Biochem Biophys; 2001 Feb; 386(2):123-35. PubMed ID: 11368334
[TBL] [Abstract][Full Text] [Related]
7. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
Korotchkina LG; Sidhu S; Patel MS
Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
[TBL] [Abstract][Full Text] [Related]
8. Critical role of a lipoyl cofactor of the dihydrolipoyl acetyltransferase in the binding and enhanced function of the pyruvate dehydrogenase kinase.
Radke GA; Ono K; Ravindran S; Roche TE
Biochem Biophys Res Commun; 1993 Feb; 190(3):982-91. PubMed ID: 8439347
[TBL] [Abstract][Full Text] [Related]
9. Specific ion influences on self-association of pyruvate dehydrogenase kinase isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the lipoyl group-binding site inhibitor, Nov3r.
Hiromasa Y; Yan X; Roche TE
Biochemistry; 2008 Feb; 47(8):2312-24. PubMed ID: 18220415
[TBL] [Abstract][Full Text] [Related]
10. Refolding and reconstitution studies on the transacetylase-protein X (E2/X) subcomplex of the mammalian pyruvate dehydrogenase complex: evidence for specific binding of the dihydrolipoamide dehydrogenase component to sites on reassembled E2.
McCartney RG; Sanderson SJ; Lindsay JG
Biochemistry; 1997 Jun; 36(22):6819-26. PubMed ID: 9184165
[TBL] [Abstract][Full Text] [Related]
11. Amino-terminal residues 1-45 of the Escherichia coli pyruvate dehydrogenase complex E1 subunit interact with the E2 subunit and are required for activity of the complex but not for reductive acetylation of the E2 subunit.
Park YH; Wei W; Zhou L; Nemeria N; Jordan F
Biochemistry; 2004 Nov; 43(44):14037-46. PubMed ID: 15518552
[TBL] [Abstract][Full Text] [Related]
12. Assembly and full functionality of recombinantly expressed dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex.
Yang D; Song J; Wagenknecht T; Roche TE
J Biol Chem; 1997 Mar; 272(10):6361-9. PubMed ID: 9045657
[TBL] [Abstract][Full Text] [Related]
13. Formation of a complex of the catalytic subunit of pyruvate dehydrogenase phosphatase isoform 1 (PDP1c) and the L2 domain forms a Ca2+ binding site and captures PDP1c as a monomer.
Turkan A; Hiromasa Y; Roche TE
Biochemistry; 2004 Nov; 43(47):15073-85. PubMed ID: 15554715
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.
Roche TE; Hiromasa Y
Cell Mol Life Sci; 2007 Apr; 64(7-8):830-49. PubMed ID: 17310282
[TBL] [Abstract][Full Text] [Related]
15. Properties of the pyruvate dehydrogenase kinase bound to and separated from the dihydrolipoyl transacetylase-protein X subcomplex and evidence for binding of the kinase to protein X.
Rahmatullah M; Jilka JM; Radke GA; Roche TE
J Biol Chem; 1986 May; 261(14):6515-23. PubMed ID: 3700404
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate dehydrogenase kinase activity of pig heart pyruvate dehydrogenase (E1 component of pyruvate dehydrogenase complex).
Kerbey AL; Randle PJ
Biochem J; 1985 Nov; 231(3):523-9. PubMed ID: 3840997
[TBL] [Abstract][Full Text] [Related]
17. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.
Knoechel TR; Tucker AD; Robinson CM; Phillips C; Taylor W; Bungay PJ; Kasten SA; Roche TE; Brown DG
Biochemistry; 2006 Jan; 45(2):402-15. PubMed ID: 16401071
[TBL] [Abstract][Full Text] [Related]
18. Partial activation of the pyruvate dehydrogenase kinase by the lipoyl domain region of E2 and interchange of the kinase between lipoyl domain regions.
Ono K; Radke GA; Roche TE; Rahmatullah M
J Biol Chem; 1993 Dec; 268(35):26135-43. PubMed ID: 8253731
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2.
Hiromasa Y; Hu L; Roche TE
J Biol Chem; 2006 May; 281(18):12568-79. PubMed ID: 16517984
[TBL] [Abstract][Full Text] [Related]
20. The regulatory properties of kidney pyruvate dehydrogenase complex components.
Pawelczyk T; Olson MS
Arch Biochem Biophys; 1993 Jan; 300(1):489-94. PubMed ID: 8424684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
